IL117516A - Injectable composition containing an oestrogenic component and a gestagenic component - Google Patents

Injectable composition containing an oestrogenic component and a gestagenic component

Info

Publication number
IL117516A
IL117516A IL11751696A IL11751696A IL117516A IL 117516 A IL117516 A IL 117516A IL 11751696 A IL11751696 A IL 11751696A IL 11751696 A IL11751696 A IL 11751696A IL 117516 A IL117516 A IL 117516A
Authority
IL
Israel
Prior art keywords
component
composition containing
oestrogenic
gestagenic
injectable composition
Prior art date
Application number
IL11751696A
Other versions
IL117516A0 (en
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Publication of IL117516A0 publication Critical patent/IL117516A0/en
Publication of IL117516A publication Critical patent/IL117516A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30—Oestrogens

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Endocrinology (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Reproductive Health (AREA)
  • Gynecology & Obstetrics (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
IL11751696A 1995-03-16 1996-03-17 Injectable composition containing an oestrogenic component and a gestagenic component IL117516A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19510861A DE19510861A1 (en) 1995-03-16 1995-03-16 One-month injection as a depot contraceptive and for hormone replacement therapy for peri- and premenopausal women

Publications (2)

Publication Number Publication Date
IL117516A0 IL117516A0 (en) 1996-07-23
IL117516A true IL117516A (en) 2000-07-26

Family

ID=7757668

Family Applications (1)

Application Number Title Priority Date Filing Date
IL11751696A IL117516A (en) 1995-03-16 1996-03-17 Injectable composition containing an oestrogenic component and a gestagenic component

Country Status (17)

Country Link
EP (1) EP0814811A1 (en)
JP (1) JPH11501649A (en)
KR (1) KR19980703058A (en)
AR (1) AR002283A1 (en)
AU (1) AU713258B2 (en)
CA (1) CA2215382A1 (en)
CZ (1) CZ289697A3 (en)
DE (1) DE19510861A1 (en)
HU (1) HUP9801691A3 (en)
IL (1) IL117516A (en)
MX (1) MX9707009A (en)
NO (1) NO974255L (en)
NZ (1) NZ304027A (en)
PL (1) PL322202A1 (en)
SK (1) SK123997A3 (en)
WO (1) WO1996028165A1 (en)
ZA (1) ZA962177B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0000313D0 (en) 2000-01-10 2000-03-01 Astrazeneca Uk Ltd Formulation

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4826831A (en) * 1983-08-05 1989-05-02 Pre Jay Holdings Limited Method of hormonal treatment for menopausal or post-menopausal disorders involving continuous administration of progestogens and estrogens

Also Published As

Publication number Publication date
AR002283A1 (en) 1998-03-11
PL322202A1 (en) 1998-01-19
HUP9801691A2 (en) 1998-11-30
IL117516A0 (en) 1996-07-23
JPH11501649A (en) 1999-02-09
MX9707009A (en) 1997-11-29
AU713258B2 (en) 1999-11-25
WO1996028165A1 (en) 1996-09-19
CA2215382A1 (en) 1996-09-19
NO974255D0 (en) 1997-09-15
KR19980703058A (en) 1998-09-05
DE19510861A1 (en) 1996-09-19
EP0814811A1 (en) 1998-01-07
NZ304027A (en) 2000-05-26
NO974255L (en) 1997-11-14
ZA962177B (en) 1996-07-29
HUP9801691A3 (en) 1999-03-01
CZ289697A3 (en) 1997-12-17
AU5110896A (en) 1996-10-02
SK123997A3 (en) 1998-02-04

Similar Documents

Publication Publication Date Title
IL119358A (en) Ink composition and a method for its preparation
IL115399A0 (en) A pharmaceutical composition comprising a combination of prostacyclin with an estrogen or progestin
HUP9903536A3 (en) Pharmaceutical composition stabilized with a basic agent
HK1210708A1 (en) Hormonal composition consisting of an oestrogen compound and of a progestational compound
PL329442A1 (en) Compositions containing a mycocide and an acetate buffer
EP0768038A3 (en) Shortening and its use
GB9500856D0 (en) Composition and use
AP9901563A0 (en) Compositions containing an a tifungal and a phospholipid
AU2523897A (en) A circulator and components thereof
GB9626811D0 (en) Component placement
IL112117A0 (en) Steroidal glycosides
ZA951578B (en) An injectable composition and a method of producing the same
ZA959313B (en) A delivery system for agents and composition
GB2274840B (en) Composition and device incorporating it
IL117516A0 (en) An injectable composition containing an oestrogenic component and a gestagenic component
GB9418957D0 (en) Filler and coating composition for paper
PL324698A1 (en) Ribosomal fraction and composition containing same
IL124430A0 (en) An envelope and an envelope construction
GB9521286D0 (en) Dosage and usage indicator
NZ298969A (en) Oral composition containing a lipophilic compound and an aminoalkylsilicone compound
ZA987559B (en) Explosives gasser composition and method
EP0843548A4 (en) Stabilized steroid compositions
ZA9510653B (en) Prestress grout bag and filler valve therefor
ZA961590B (en) A grout composition
GB9512703D0 (en) Composition and use

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees